Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for id:"handle:10037/20354". One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Universitetet i Tromsø

1. Hardersen, Randolf Inge. Biocompatibility in low-density lipoprotein apheresis and plasma separation .

Degree: 2021, Universitetet i Tromsø

<i>Introduction:</i> Low-density lipoprotein (LDL) apheresis is used for the removal of LDL in selected patients and is also used for other medical indications. This thesis aimed to systematically study how different LDL apheresis systems affected the immune system in a biocompatibility perspective under in vivo and ex vivo conditions. <i>Methods:</i> Whole blood adsorption, dextran sulfate plasma adsorption, and double filtration plasma LDL apheresis systems were studied using a human whole blood model differentiating the effect of the lipoprotein apheresis and plasma separation columns, also describing temporal changes. <i>Results:</i> The in vivo study showed equal complement activation with all devices. Cytokines were consistently either increased, decreased, or unchanged. The ex vivo studies showed that the whole blood system was inert with regard to complement activation. The whole blood system reduced cytokine concentration and the plasma separation column can be a barrier to the reduction of eotaxin. Differences in temporal concentration changes were revealed for PDGF-BB and IP10. CD11b expression was complement factor 5 (C5) dependent and a possible C5 dependence for granulocyte-platelet conjugates formation was indicated. <i>Conclusion:</i> There are marked differences in how the three LDL apheresis systems affect the immune system. Low-density lipoprotein apheresis can modulate the immune system which possibly can be beneficial for the patient when used for medical indications other than LDL lowering. The results underline the importance of testing LDL apheresis systems independently for each medical indication they are used, other than the removal of lipoproteins, and to take temporal changes into account when developing treatment regimes. Advisors/Committee Members: Hovland, Anders (advisor), LappegÄrd, Knut Tore (advisor).

Subjects/Keywords: 710:Medisinsk immunologi; VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical immunology: 716; Biocompatibility; Plasma separation; Low-density lipoprotein apheresis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hardersen, R. I. (2021). Biocompatibility in low-density lipoprotein apheresis and plasma separation . (Doctoral Dissertation). Universitetet i Tromsø. Retrieved from http://hdl.handle.net/10037/20354

Chicago Manual of Style (16th Edition):

Hardersen, Randolf Inge. “Biocompatibility in low-density lipoprotein apheresis and plasma separation .” 2021. Doctoral Dissertation, Universitetet i Tromsø. Accessed March 01, 2021. http://hdl.handle.net/10037/20354.

MLA Handbook (7th Edition):

Hardersen, Randolf Inge. “Biocompatibility in low-density lipoprotein apheresis and plasma separation .” 2021. Web. 01 Mar 2021.

Vancouver:

Hardersen RI. Biocompatibility in low-density lipoprotein apheresis and plasma separation . [Internet] [Doctoral dissertation]. Universitetet i Tromsø 2021. [cited 2021 Mar 01]. Available from: http://hdl.handle.net/10037/20354.

Council of Science Editors:

Hardersen RI. Biocompatibility in low-density lipoprotein apheresis and plasma separation . [Doctoral Dissertation]. Universitetet i Tromsø 2021. Available from: http://hdl.handle.net/10037/20354

.